Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

May 24 2000
(Michael J. Werner, Director of Federal Government Relations/Bioethics Counsel for the Biotechnology Industry Organization (BIO), issued the following...
May 17 2000
WASHINGTON, D.C. and OAKLAND, Calif., May 17, 2000 The Biotechnology Industry Organization (BIO) and DoubleTwist Inc. today announced they signed a letter of...
May 15 2000
WASHINGTON, D.C., (May 15, 2000) - BIO anticipatesrecord-breaking attendance at its Legislative Day here Tuesday and Wednesday, May 16 - 17, with about 150...
May 12 2000
WASHINGTON, D.C. (May 12, 2000) Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement concerning a Maine...
May 3 2000
(Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today regarding FDA Commissioner Jane Henney’s...
May 1 2000
A Position Paper fromThe Biotechnology Industry Organization Executive Summary 1. Human organ transplantation faces a significant challenge because the need...
Apr 26 2000
WASHINGTON, D.C. (April 26, 2000) Dr. Joanna C. Horobin, testifying on behalf of the Biotechnology Industry Organization (BIO), said today the Clinton...
Apr 26 2000
WASHINGTON, D.C. (April 26, 2000) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement in response to...
Apr 14 2000
WASHINGTON, D.C. (April 14, 2000) The BiotechnologyIndustry Organization (BIO) has put together a coalition of entrepreneurial associations to support full...


Biotechnology News

September 1, 2014

DUBLIN--(BUSINESS WIRE)--Research and Markets (...

September 1, 2014

MUNICH--(BUSINESS WIRE)--Diaverum, one of the world’s leading renal care providers today announced changes to its Executive Team and its underlying area structure. The...

September 1, 2014

OSLO, Norway--(BUSINESS WIRE)--Nordic Nanovector (the “Company”) announces that the subscription period for the previously announced subsequent repair offering (the “...

September 1, 2014

CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE Healthcare announced today that VIZAMYL™ (flutemetamol (18F) solution for injection) has received marketing authorisation...